BD Marks Milestone with First Phasix Hernia Prevention Case in Greece and Over 85% Enrollment in U.S. PREVENT Trial
BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow Cytometry
